MiNK Therapeutics, Inc. (INKT) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -1.73B | -2.07M | -941.35K | -1.57M | -1.34B | -1.73M | -2.99M | -2.29M | -2.54M | -3.04M | -4.21M | -4.15M | -4.37M | -4.43M | -5.61M | -4.63M | -4.2M | -1.7M | -3.5M | -3.42M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -29.21% | -20.03% | 68.57% | 31.5% | -52644.56% | 43.09% | 28.85% | 44.82% | 41.78% | 31.48% | 25.03% | 10.25% | -4.05% | -160.27% | -60.61% | -35.23% | 0.29% | 0.9% | - | - |
| Net Income | -2.74B | -12.48B | -2.89M | -4.24M | -2.77M | -2.46M | -1.81M | -2.7M | -3.81M | -5.46M | -5.12M | -6.2M | -5.69M | -7.77M | -6.33M | -6.11M | -7.78M | -5.76M | -14.27M | -6.34M |
| Depreciation & Amortization | 36.07M | 181.6M | 43.65K | 48.76K | 50.77K | 53.87K | 62.64K | 45.1K | 53.83K | 53.57K | 53.45K | 51.91K | 45.69K | 37.93K | 28.43K | 28.31K | 27.08K | 23.83K | 20.29K | 17.65K |
| Stock-Based Compensation | 630.39M | 2.67B | 620.59K | 896.55K | 591.09K | 390.05K | 883K | 436.87K | 592.01K | 1.1M | 939.26K | 898.26K | 921.14K | 0 | 772.9K | 800.81K | 785.51K | 667.03K | 387.36K | 407.3K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 939K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 342.98M | 9.63B | 221.11K | 555.91K | -1.34B | 312.97K | -2.07M | 8.79K | 4.44K | 0 | -939K | -266.78K | 0 | 666.89K | 0 | -2.79M | 0 | 49.43K | 9.75M | 1.96M |
| Working Capital Changes | 343.32K | 469.36K | 1.06M | 1.17M | 591.04K | -21.45K | -60K | -79.63K | 620.81K | 1.27M | -85.6K | 1.36M | 352.81K | 2.63M | -84.44K | 3.45M | 2.77M | 3.32M | 610.26K | 525.08K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -32.41K | -269.6K | 381.85K | 646.06K | -68.61K | 374.15K | -847.35K | -284.77K | -424.44K | -373.34K | -578.31K | -1.12M | 153.92K | 570.31K | 480.17K | 968.07K | 642.23K | 1.35M | -614.14K | -583.96K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23.04K | -37.02K | -13.5K | -127.84K | -59.8K | -62.41K | 0 | 277 | -111.82K | -97.92K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23.04K | -37.02K | -13.5K | -127.84K | -59.8K | -62.41K | 0 | 277 | -111.82K | -97.92K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -2.1B | 1.18M | 13.55M | 540 | 576K | -3 | 6.8K | 5.81M | 5.01M | -2 | 2.95K | -75.7K | -334.43K | 111 | 494 | -156.89K | 689 | 39.8M | 2.78M | 4.35M |
| Debt Issued (Net) | -5M | 0 | 0 | 0 | 0 | -5M | 0 | 0 | 5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -76 | 2.78M | 4.35M |
| Equity Issued (Net) | 3.15M | 1.35M | 13.55M | 540 | 576 | -3 | 6.8K | 5.8M | 6.9K | -2 | 0 | -97.72K | -379.92K | 111 | 494 | -157.19K | 689 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -3 | 0 | 0 | 0 | -2 | 0 | -97.72K | -379.92K | 0 | 0 | -157.19K | 0 | 0 | 0 | 0 |
| Other Financing | -2.1B | -173.35K | 0 | 0 | 575.42K | 5M | 0 | 6.29K | 0 | 0 | 2.95K | 22.02K | 45.5K | 0 | 0 | 301 | 0 | 39.8M | 150 | 0 |
| Net Change in Cash | -3.83B | -920.87K | 12.6M | -1.55M | -1.34B | -1.75M | -2.99M | 3.5M | 2.45M | -3.03M | -4.22M | -4.27M | -4.74M | -4.52M | -5.69M | -4.84M | -4.2M | 38.07M | -838.9K | 848.07K |
| Free Cash Flow | -1.73B | -2.07M | -941.35K | -1.57M | -1.34B | -1.73M | -2.99M | -2.29M | -2.54M | -3.04M | -4.23M | -4.19M | -4.38M | -4.56M | -5.67M | -4.69M | -4.2M | -1.7M | -3.61M | -3.52M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -29.21% | -20.03% | 68.57% | 31.5% | -52644.56% | 43.09% | 29.23% | 45.3% | 41.96% | 33.4% | 25.42% | 10.66% | -4.37% | -167.82% | -57.29% | -33.24% | 1.22% | 0.91% | - | - |
| FCF per Share | -361.11 | -0.49 | -0.21 | -0.39 | -338.18 | -0.46 | -0.76 | -0.62 | -0.73 | -0.88 | -1.23 | -1.22 | -1.29 | -1.35 | -1.68 | -1.39 | -1.25 | -0.52 | -1.10 | -1.24 |
| FCF Conversion (FCF/Net Income) | 631.79x | 0.80x | 0.33x | 0.37x | 484.65x | 0.70x | 1.66x | 0.85x | 0.67x | 0.56x | 0.82x | 0.67x | 0.77x | 0.57x | 0.89x | 0.76x | 0.54x | 0.30x | 0.25x | 0.54x |
| Interest Paid | 0 | -2.02K | 0 | 2.02K | 0 | 4.11K | 0 | 0 | 0 | 6.07K | 0 | 0 | 9.96K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |